Form 4: NeueHealth CFO Jay Matushak Reports Stock Sales Following RSU Vesting

NeueHealth's CFO, Jay Matushak, reported the sale of company stock to cover tax obligations following the vesting of restricted stock units.

Summary

• On March 11, 2025, Jay Matushak, CFO of NeueHealth, Inc., sold 814 shares of common stock at a weighted average price of $6.85 per share to cover tax withholding obligations related to vesting restricted stock units.
• On March 12, 2025, Matushak exercised 24,000 restricted stock units (RSUs) which converted into common stock.
• Also on March 12, 2025, Matushak sold 1,633 shares of common stock at a weighted average price of $6.93 per share.
• Following these transactions, Matushak directly owns 46,040 shares of NeueHealth common stock and 48,000 restricted stock units.
• The RSUs vest in three equal annual installments beginning on March 11, 2025.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for company insiders reporting transactions in their company's stock, providing transparency to investors.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for corporate insiders in the US, ensuring transparency in stock transactions.
• Similar filings are expected from executives at comparable healthcare companies like Oak Street Health (OSH) and Alignment Healthcare (ALHC) when they trade their company's stock.
• The reported transactions are typical for executives receiving stock-based compensation and managing their personal finances.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely minimal given the relatively small volume of shares sold.

Key Dates